Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_assertion type Assertion NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_head.
- NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_assertion description "[Because ASXL1 lesions have been increasingly identified in myeloid neoplasms, we examined the relationships of ASXL1 mutation or deletion to both clinical phenotype and associated molecular features in 166 patients with myeloproliferative neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_provenance.
- NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_assertion evidence source_evidence_literature NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_provenance.
- NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_assertion SIO_000772 21712540 NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_provenance.
- NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_assertion wasDerivedFrom befree-20150227 NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_provenance.
- NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_assertion wasGeneratedBy ECO_0000203 NP978552.RA3SUp4R3OHn8Nr0NmvtKveVVHd_c7xEuyWQc_pZJseSA130_provenance.